• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Location and Density of Immune Cells in Precursor Lesions and Cervical Cancer.前驱病变和宫颈癌中免疫细胞的位置与密度
Cancer Microenviron. 2013 Apr;6(1):69-77. doi: 10.1007/s12307-012-0097-8. Epub 2012 Jan 31.
2
Infiltrating CD4 and CD8 lymphocytes in HPV infected uterine cervical milieu.人乳头瘤病毒(HPV)感染的子宫颈环境中的浸润性CD4和CD8淋巴细胞
Cancer Manag Res. 2019 Aug 14;11:7647-7655. doi: 10.2147/CMAR.S217264. eCollection 2019.
3
MMP-9/RECK Imbalance: A Mechanism Associated with High-Grade Cervical Lesions and Genital Infection by Human Papillomavirus and Chlamydia trachomatis.基质金属蛋白酶-9/RECK失衡:一种与高级别宫颈病变以及人乳头瘤病毒和沙眼衣原体所致生殖器感染相关的机制
Cancer Epidemiol Biomarkers Prev. 2015 Oct;24(10):1539-47. doi: 10.1158/1055-9965.EPI-15-0420. Epub 2015 Aug 10.
4
T- and NK-cell populations with regulatory phenotype and markers of apoptosis in circulating lymphocytes of patients with CIN3 or microcarcinoma of the cervix: evidence for potential mechanisms of immune suppression.CIN3或宫颈微癌患者循环淋巴细胞中具有调节表型和凋亡标志物的T细胞和NK细胞群体:免疫抑制潜在机制的证据
Infect Agent Cancer. 2017 Oct 17;12:56. doi: 10.1186/s13027-017-0166-1. eCollection 2017.
5
6
Human papillomavirus types in cervical high-grade lesions or cancer among Nordic women-Potential for prevention.北欧女性宫颈高级别病变或癌症中的人乳头瘤病毒类型——潜在的预防目标。
Cancer Med. 2019 Feb;8(2):839-849. doi: 10.1002/cam4.1961. Epub 2019 Jan 11.
7
Stromal PD-L1-Positive Regulatory T cells and PD-1-Positive CD8-Positive T cells Define the Response of Different Subsets of Non-Small Cell Lung Cancer to PD-1/PD-L1 Blockade Immunotherapy.基质 PD-L1 阳性调节性 T 细胞和 PD-1 阳性 CD8 阳性 T 细胞定义了不同亚组非小细胞肺癌对 PD-1/PD-L1 阻断免疫治疗的反应。
J Thorac Oncol. 2018 Apr;13(4):521-532. doi: 10.1016/j.jtho.2017.11.132. Epub 2017 Dec 18.
8
B7-H4 overexpression impairs the immune response of T cells in human cervical carcinomas.B7-H4过表达会损害人宫颈癌中T细胞的免疫反应。
Hum Immunol. 2014 Dec;75(12):1203-9. doi: 10.1016/j.humimm.2014.10.002. Epub 2014 Oct 13.
9
Human papillomavirus type 16 (HPV-16) virus-like particle L1-specific CD8+ cytotoxic T lymphocytes (CTLs) are equally effective as E7-specific CD8+ CTLs in killing autologous HPV-16-positive tumor cells in cervical cancer patients: implications for L1 dendritic cell-based therapeutic vaccines.人乳头瘤病毒16型(HPV - 16)病毒样颗粒L1特异性CD8 + 细胞毒性T淋巴细胞(CTL)在杀死宫颈癌患者自体HPV - 16阳性肿瘤细胞方面与E7特异性CD8 + CTL同样有效:对基于L1树突状细胞的治疗性疫苗的启示。
J Virol. 2009 Jul;83(13):6779-89. doi: 10.1128/JVI.02443-08. Epub 2009 Apr 22.
10
Diagnostic accuracy of cervical cancer screening and screening-triage strategies among women living with HIV-1 in Burkina Faso and South Africa: A cohort study.布基纳法索和南非艾滋病毒 1 型感染者中宫颈癌筛查和筛查分流策略的诊断准确性:一项队列研究。
PLoS Med. 2021 Mar 4;18(3):e1003528. doi: 10.1371/journal.pmed.1003528. eCollection 2021 Mar.

引用本文的文献

1
The immune microenvironment of cancer of the uterine cervix.宫颈癌的免疫微环境。
Histol Histopathol. 2024 Oct;39(10):1245-1271. doi: 10.14670/HH-18-727. Epub 2024 Mar 1.
2
Tumor Immune Microenvironment in Gynecologic Cancers.妇科癌症中的肿瘤免疫微环境
Cancers (Basel). 2023 Jul 28;15(15):3849. doi: 10.3390/cancers15153849.
3
Immunological Aspects of Human Papilloma Virus-Related Cancers Always Says, "I Am like a Box of Complexity, You Never Know What You Are Gonna Get".人乳头瘤病毒相关癌症的免疫学方面总是说:“我就像一盒复杂性,你永远不知道你会得到什么”。
Vaccines (Basel). 2022 May 6;10(5):731. doi: 10.3390/vaccines10050731.
4
Prognostic and therapeutic TILs of cervical cancer-Current advances and future perspectives.宫颈癌的预后和治疗性肿瘤浸润淋巴细胞——当前进展与未来展望
Mol Ther Oncolytics. 2021 Jul 21;22:410-430. doi: 10.1016/j.omto.2021.07.006. eCollection 2021 Sep 24.
5
Infiltrating T-cell markers in cervical carcinogenesis: a systematic review and meta-analysis.浸润性 T 细胞标志物在宫颈癌发生中的作用:系统评价和荟萃分析。
Br J Cancer. 2021 Feb;124(4):831-841. doi: 10.1038/s41416-020-01184-x. Epub 2020 Dec 1.
6
HPV Induces Changes in Innate Immune and Adhesion Molecule Markers in Cervical Mucosa With Potential Impact on HIV Infection.人乳头瘤病毒可诱导宫颈黏膜中固有免疫和黏附分子标志物发生变化,这可能对艾滋病毒感染产生影响。
Front Immunol. 2020 Sep 3;11:2078. doi: 10.3389/fimmu.2020.02078. eCollection 2020.
7
Infiltrating CD4 and CD8 lymphocytes in HPV infected uterine cervical milieu.人乳头瘤病毒(HPV)感染的子宫颈环境中的浸润性CD4和CD8淋巴细胞
Cancer Manag Res. 2019 Aug 14;11:7647-7655. doi: 10.2147/CMAR.S217264. eCollection 2019.
8
The impact of genetic variants in IL1R2 on cervical cancer risk among Uygur females from China: A case-control study.IL1R2基因变异对中国维吾尔族女性宫颈癌风险的影响:一项病例对照研究。
Mol Genet Genomic Med. 2019 Jan;7(1):e00516. doi: 10.1002/mgg3.516. Epub 2018 Nov 20.
9
An Altered Ratio of CD4+ And CD8+ T Lymphocytes in Cervical Cancer Tissues and Peripheral Blood – A Prognostic Clue?宫颈癌组织和外周血中CD4+和CD8+ T淋巴细胞比例的改变——一个预后线索?
Asian Pac J Cancer Prev. 2018 Feb 26;19(2):471-478. doi: 10.22034/APJCP.2018.19.2.471.
10
Relationships between Common and Novel Interleukin-6 Gene Polymorphisms and Risk of Cervical Cancer: a Case-Control Study.常见和新型白细胞介素-6基因多态性与宫颈癌风险的关系:一项病例对照研究
Pathol Oncol Res. 2017 Apr;23(2):385-392. doi: 10.1007/s12253-016-0127-9. Epub 2016 Oct 8.

本文引用的文献

1
Tumor-infiltrating lymphocytes contain a higher proportion of FOXP3(+) T lymphocytes in cervical cancer.在宫颈癌患者肿瘤浸润淋巴细胞中 FOXP3(+)T 淋巴细胞的比例更高。
J Formos Med Assoc. 2011 Sep;110(9):580-6. doi: 10.1016/j.jfma.2011.07.005. Epub 2011 Aug 12.
2
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008.2008 年全球癌症负担估计值:GLOBOCAN 2008。
Int J Cancer. 2010 Dec 15;127(12):2893-917. doi: 10.1002/ijc.25516.
3
Tumor microenvironment is multifaceted.肿瘤微环境是多方面的。
Cancer Metastasis Rev. 2011 Mar;30(1):13-25. doi: 10.1007/s10555-011-9279-y.
4
Early natural history of incident, type-specific human papillomavirus infections in newly sexually active young women.新性活跃年轻女性中 HPV 感染的自然史。
Cancer Epidemiol Biomarkers Prev. 2011 Apr;20(4):699-707. doi: 10.1158/1055-9965.EPI-10-1108. Epub 2010 Dec 20.
5
Human papillomavirus 16-associated cervical intraepithelial neoplasia in humans excludes CD8 T cells from dysplastic epithelium.人乳头瘤病毒 16 型相关的宫颈上皮内瘤变在人类中可使 CD8+T 细胞排除于发育不良的上皮之外。
J Immunol. 2010 Dec 1;185(11):7107-14. doi: 10.4049/jimmunol.1002756. Epub 2010 Oct 29.
6
HPV - immune response to infection and vaccination.HPV - 感染和疫苗接种的免疫反应。
Infect Agent Cancer. 2010 Oct 20;5:19. doi: 10.1186/1750-9378-5-19.
7
An unexpectedly large polyclonal repertoire of HPV-specific T cells is poised for action in patients with cervical cancer.在宫颈癌患者中,存在着大量出乎意料的 HPV 特异性 T 细胞多克隆库,随时准备发挥作用。
Cancer Res. 2010 Apr 1;70(7):2707-17. doi: 10.1158/0008-5472.CAN-09-4299. Epub 2010 Mar 16.
8
Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2/3: critical role of duration of infection.人乳头瘤病毒持续感染与宫颈上皮内瘤变 2/3 级的纵向研究:感染持续时间的关键作用。
J Natl Cancer Inst. 2010 Mar 3;102(5):315-24. doi: 10.1093/jnci/djq001. Epub 2010 Feb 15.
9
Signaling defects and functional impairment in T-cells from cervical cancer patients.宫颈癌患者 T 细胞的信号缺陷和功能障碍。
Cancer Biother Radiopharm. 2009 Dec;24(6):667-73. doi: 10.1089/cbr.2009.0660.
10
Short term persistence of human papillomavirus and risk of cervical precancer and cancer: population based cohort study.人乳头瘤病毒的短期持续感染与宫颈癌前病变及癌症风险:基于人群的队列研究
BMJ. 2009 Jul 28;339:b2569. doi: 10.1136/bmj.b2569.

前驱病变和宫颈癌中免疫细胞的位置与密度

Location and Density of Immune Cells in Precursor Lesions and Cervical Cancer.

作者信息

Bedoya Astrid M, Jaramillo Roberto, Baena Armando, Castaño Jorge, Olaya Natalia, Zea Arnold H, Herrero Rolando, Sanchez Gloria I

机构信息

Grupo Infección y Cáncer, Facultad de Medicina, Universidad de Antioquia, Cra 51D No. 62-29 Lab 283, Medellin, Colombia.

Escuela de Microbiología, Universidad de Antioquia, Medellin, Colombia.

出版信息

Cancer Microenviron. 2013 Apr;6(1):69-77. doi: 10.1007/s12307-012-0097-8. Epub 2012 Jan 31.

DOI:10.1007/s12307-012-0097-8
PMID:22290207
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3601215/
Abstract

Only a small proportion of women infected with Human Papillomavirus (HPV) develop cervical cancer. Host immune response seems to play a role eliminating the viral infection and preventing progression to cancer. Characterization of tumor infiltrating lymphocytes (TILs) in cervical pre-neoplastic lesions and cervical cancer may be helpful to understand the mechanisms that mediate this protection. The aim of this study was to determine if there are differences in the localization and density (cells/mm(2)) of CD8+ T-cells, CD4+ T-cells and Tregs (CD25 + Foxp3+) in cervical pre-neoplastic lesions and cervical cancer. Immunohistochemical analysis of sections of 96 (26 CIN1, 21 CIN2, 25 CIN3, and 24 SCC) samples revealed that regardless of CIN grades, CD8+ T-cells are more abundant than CD4+, CD25+ and Foxp3+ cells in both the stroma and epithelium. There was a higher density of CD8+ cells in the stroma of cervical cancer compared to CIN3 (OR = 4.20, 95% CI 1.2-15), CIN2 (OR = 7.86, 95% CI 1.7-36.4) and CIN1 (OR = 4.25, 95% CI 1.1-17). Studies evaluating whether these cells are recruited before or after cancer progression will be helpful to understand the role of these cells in the natural history of HPV-induced lesions.

摘要

只有一小部分感染人乳头瘤病毒(HPV)的女性会患上宫颈癌。宿主免疫反应似乎在消除病毒感染和预防癌症进展方面发挥作用。对宫颈癌前病变和宫颈癌中的肿瘤浸润淋巴细胞(TILs)进行特征分析,可能有助于了解介导这种保护作用的机制。本研究的目的是确定宫颈前病变和宫颈癌中CD8 + T细胞、CD4 + T细胞和调节性T细胞(CD25 + Foxp3 +)在定位和密度(细胞/mm²)上是否存在差异。对96个样本(26个CIN1、21个CIN2、25个CIN3和24个鳞状细胞癌)的切片进行免疫组织化学分析显示,无论CIN分级如何,基质和上皮中的CD8 + T细胞均比CD4 +、CD25 +和Foxp3 +细胞丰富。与CIN3(OR = 4.20,95% CI 1.2 - 15)、CIN2(OR = 7.86,95% CI 1.7 - 36.4)和CIN1(OR = 4.25,95% CI 1.1 - 17)相比,宫颈癌基质中CD8 +细胞的密度更高。评估这些细胞是在癌症进展之前还是之后被招募的研究,将有助于了解这些细胞在HPV诱导病变自然史中的作用。